Park Avenue Securities LLC Intra Cellular Therapies, Inc. Transaction History
Park Avenue Securities LLC
- $8.9 Billion
- Q3 2024
A detailed history of Park Avenue Securities LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Park Avenue Securities LLC holds 5,190 shares of ITCI stock, worth $395,010. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,190
Previous 5,875
11.66%
Holding current value
$395,010
Previous $402,000
5.47%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ITCI
# of Institutions
398Shares Held
87.2MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$731 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$481 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$283 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$261 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$228 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $7.18B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...